GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (FRA:OWX) » Definitions » Deferred Policy Acquisition Costs

Ypsomed Holding AG (FRA:OWX) Deferred Policy Acquisition Costs


View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG Deferred Policy Acquisition Costs?

Deferred Policy Acquisition Costs only applies to banks and insurance companies.


Ypsomed Holding AG (FRA:OWX) Business Description

Traded in Other Exchanges
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.